Dragon Pharma PE 22-28 is supplied as a lyophilized powder in a 2 mL vial and contains the synthetic peptide PE 22-28 at a labeled strength of 10 mg. Product specifications, storage information, and available payment options are provided below.
10 mg Peptide Strength
Each vial contains a labeled strength of 10 mg of PE 22-28.
Lyophilized Powder Form
Supplied as a freeze-dried powder that requires reconstitution with bacteriostatic water before use.
2 mL Vial
Packaged in a standard 2 mL peptide vial with a rubber stopper and aluminum seal.
Neuro/Cognitive Research
PE 22-28 has been investigated in preclinical research for its potential effects on cognitive function and neural pathways.
Product Specifications
Product name
PE 22-28 10 mg
Active substance
PE 22-28
Labeled strength
10 mg/vial
Container
2 mL vial
Total labeled content
10 mg per vial
Product form
Lyophilized powder
Manufacturer
Dragon Pharma
Related Peptide Options
Other peptide options from the same product line include Semax 5 mg, a peptide investigated for cognitive and neuroprotective effects, and Selank 10 mg, which has been studied for its potential effects on anxiety and cognitive function. These products differ in their structure and the research applications for which they are used.
Science & Research
Understanding PE 22-28
PE 22-28 is a synthetic peptide that has been investigated in preclinical research for its potential effects on cognitive function and neural pathways. This section provides a brief overview of what is known about this peptide from research literature.
1
Synthetic Peptide
PE 22-28 is a synthetic peptide that has been studied in research settings for its potential effects on cognitive function and neural pathways. Its structure is designed for specific biological activity in research applications.
2
Research Applications
Preclinical research has investigated PE 22-28 for its potential effects on cognitive function and related neural processes. The peptide has been studied in laboratory settings for its interactions with cellular pathways involved in neural function.
3
Mechanism of Action
The precise mechanism of action of PE 22-28 is not fully characterized. Research suggests it may influence neural pathways through specific cellular targets, though the exact molecular mechanisms remain an area of ongoing investigation.
Peptide Reconstitution and Use
This product is supplied as a lyophilized powder and must be reconstituted with bacteriostatic water or sterile water for injection before use. The addition of water converts the freeze-dried powder into a solution suitable for research applications.
The reconstituted peptide solution should be stored as recommended on the product label. Peptide solutions are typically refrigerated and used within a specified timeframe after reconstitution to maintain integrity.
Research References
Peer-reviewed research on PE 22-28 is available through the National Institutes of Health and other scientific databases. The following link provides general information on this peptide and its mechanism of action.
Peptide research compounds such as PE 22-28 have limited clinical safety data. The information below is derived from published preclinical research and general knowledge of peptide biology and does not constitute medical advice.
Limited Clinical Data
PE 22-28 has not been extensively studied in humans. The available safety information comes primarily from preclinical research.
Neural Effects Unknown
The full range of effects of PE 22-28 on cognitive function and neural pathways is not fully characterized. The significance of its interactions with neural pathways is not completely understood.
Injection-Related Risks
Subcutaneous injection carries risks including injection-site reactions, infection and improper technique. Sterile handling and correct reconstitution procedures are essential.
Systemic Effects Unknown
The potential systemic effects of PE 22-28 and its interactions with other physiological systems are not fully understood.
Contraindications
This peptide research compound should not be used by individuals with known allergies or sensitivities to peptide compounds, or by those who are pregnant, nursing or have active malignancies.
Limited Research
The long-term effects and safety profile of PE 22-28 have not been established in any population. Research on this peptide is still in the early stages.
Conditions That Require Medical Review
Medical advice is particularly important for individuals with neurological conditions, cognitive disorders, cardiovascular disease, or those taking medications that affect the central nervous system. This peptide should not be used during pregnancy or breastfeeding.
The product should also be stored securely to prevent accidental access or use by children or other household members, particularly after reconstitution when it contains a liquid solution.
Tested Sport
PE 22-28 is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change. Some peptide compounds may fall under general prohibitions on substances with similar biological effects.
Quick answers about PE 22-28 10 mg specifications, storage, shipping, Bitcoin payment and general product information.
What is Dragon Pharma PE 22-28 10 mg?
Dragon Pharma PE 22-28 10 mg is a lyophilized peptide product containing 10 mg of the synthetic peptide PE 22-28 per vial. It is supplied in a 2 mL vial for research purposes.
What is PE 22-28?
PE 22-28 is a synthetic peptide that has been investigated in preclinical research for its potential effects on cognitive function and neural pathways.
How much peptide is in each vial?
Each vial contains a labeled strength of 10 mg of PE 22-28.
How is the product supplied?
The product is supplied as a lyophilized powder in a 2 mL vial. It requires reconstitution with bacteriostatic water or sterile water for injection before use.
How should PE 22-28 be stored?
Store the lyophilized powder in its original packaging at room temperature or refrigerated, protected from excessive heat, moisture and direct light. Once reconstituted, peptide solutions typically require refrigeration and should be used within a limited timeframe. Always follow the specific storage directions printed on the product label.
Does PE 22-28 require refrigeration?
Lyophilized peptide powders are generally stable at room temperature but should be protected from heat. After reconstitution, peptide solutions typically require refrigeration. Check the product label for specific storage instructions.
How long does PE 22-28 delivery take?
Delivery depends on the warehouse selected for the order. Shipments from the USA Warehouse typically take 4–5 business days after dispatch, while shipments from the International Warehouse typically take 15–20 business days after dispatch. Full delivery and reship information is available on the Shipping Information page.
Can I buy PE 22-28 with Bitcoin?
Yes. Bitcoin and other supported cryptocurrencies are available at checkout for all orders. To buy PE 22-28 10 mg with Bitcoin, select Bitcoin as the payment method during checkout and follow the payment instructions provided with the order.
Is Bitcoin payment anonymous?
Bitcoin transactions are recorded on a public blockchain and should not be considered automatically anonymous. Accurate order and delivery information is still required for order processing and shipping.
Is PE 22-28 permitted in tested sport?
PE 22-28 is not specifically listed on the World Anti-Doping Agency Prohibited List at the time of writing. Athletes should check the current list before competition, as prohibited substances are subject to change.
Where can I find more information on PE 22-28?
Additional research on this peptide is available through the National Institutes of Health and other scientific databases. A direct link to PubMed references is provided in the Science & Research section above.
